Infection prevention and control programme and COVID-19 measures: Effects on hospital-acquired infections in patients with cirrhosis.
JHEP Rep
; 5(5): 100703, 2023 May.
Article
en En
| MEDLINE
| ID: mdl-36844944
ALD, alcoholic liver disease; Antibiotic resistance; Antimicrobial stewardship; BB, beta-blockers; Bacterial infections; C19MC, COVID-19 measures cohort; CA, community acquired; COVID-19, coronavirus disease 2019; CRP, C-reactive protein; EATF, empiric antibiotic treatment failure; Empiric antibiotic failure; HAI, hospital-acquired infection; HCA, healthcare-associated; IPCC, infection prevention and control cohort; IPCP, infection prevention and control programme; Liver cirrhosis; MAP, mean arterial pressure; MDR, multidrug-resistant; MELD, model for end-stage liver disease; Multidrug-resistant bacteria; NASH, non-alcoholic steatohepatitis; Nosocomial infections; OR, odds ratio; PDR, pandrug-resistant; PPI, proton pump inhibitor; SARS-CoV-2; SBP, spontaneous bacterial peritonitis; SMC, standard measures cohort; UTI, urinary tract infection; WBC, white blood cell; XDR, extensively drug-resistant
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
JHEP Rep
Año:
2023
Tipo del documento:
Article
País de afiliación:
Italia